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Organelle Acidiﬁcation and Disease
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A subset of cellular compartments maintain acidic in-
terior environments that are critical for the speciﬁc
functions of each organelle and for cell growth and sur-
vival in general. The pH of each organelle reﬂects the
balance between proton pumping, counterion conduc-
tance, and proton leak. Alterations in steady-state or-
ganelle pH due to defects in either proton pumping ac-
tivity or counterion conductance have been suggested
to contribute to the pathology of several diseases;
however, deﬁnitive evidence remains elusive. This re-
view describes recent evidence for the misregulation
of organelle pH in the progression of cancer, Dent’s dis-
ease, and cystic ﬁbrosis.
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The compartmentalization of cellular processes into distinct
membrane-bound compartments with unique microenviron-
ments has enabled cells to process numerous reactions sim-
ultaneously with precision and speed. In eukaryotes, these
compartments include the organelles of the biosynthetic and
endocytic pathways, which together form a highly differen-
tiated membranous network that efﬁciently sorts and trafﬁcs
newly synthesized and internalized molecules to their in-
tended destinations. A key requirement for optimal function
of many of these compartments is the maintenance of acidic
pH lumens. Along the endocytic pathway, internalized mol-
ecules encounter successively decreasing pH in early endo-
somes, late endosomes, and lysosomes (1). Acidiﬁcation
plays multiple roles in this pathway: for example, the slightly
acidic pH of early endosomes (pH 6.2) facilitates receptor-
ligand dissociation. Similarly, the uniquely low pH of lyso-
somes (pH 4.8–5.2) enables the selective activation of lys-
osomal hydrolases once they reach this compartment. Acidi-
ﬁcation is also required for some functions of specialized
cells, such as antigen processing by immune cells [reviewed
in (2)]. In addition, many viruses and other pathogens require
access to acidiﬁed endosomal compartments in order to ef-
ﬁciently infect cells (3–5).
In contrast to the endocytic pathway, most compartments
that form the biosynthetic pathway are thought to have near-
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neutral pH. However, the trans-Golgi network (TGN), a major
sorting site for newly synthesized molecules, has been dem-
onstrated by several groups to be slightly acidiﬁed (pH 6.0)
[refs (6–8)]. Acidiﬁcation of this compartment is important
for the sorting of lysosomally destined enzymes, for the for-
mation of regulated secretory granules, and for efﬁcient
constitutive cell surface delivery or secretion of some proteins
(9,10).
Steady-state organelle pH is regulated and maintained by a
balance between the rates of intralumenal proton pumping,
counterion conductance, and intrinsic proton leak [Figure 1;
see also (11,12) for recent reviews]. Protons are pumped into
compartments against their concentration gradients by the
vacuolar-type ATPase, a large multisubunit complex with a
molecular mass of nearly 1¿106kDa. Assembly and activity
Figure1: Regulation and maintenance of organelle pH. Acidi-
ﬁed pH is generated and maintained by the balance between pro-
ton pump activity, which can be modulated by changes in mem-
brane potential, and the rate of proton efﬂux. Protons are pumped
into membranous compartments by the V-ATPase (blue). Pumping
can be inhibited by the build-up of excess positive charge (mem-
brane potential) which may be neutralized by passive inﬂux of a
counterion conductance (e.g. chloride entry, green), or by efﬂux of
another cation (not shown). Alternatively, sodium entry (mediated
by the Naπ/Kπ-ATPase, yellow) could increase membrane potential
to further inhibit V-ATPase activity and limit acidiﬁcation. In addition,
the rate of intrinsic or regulated hydrogen ion leakage from each
compartment (red) contributes signiﬁcantly to the steady-state con-
centration of protons in some organelles.Weisz
of this pump are regulated by numerous mechanisms [re-
viewed in (13)].
As the electrogenic V-ATPase pumps protons into a compart-
ment, its ability to function further is theoretically limited by
the accumulation of a positive membrane potential. In mam-
malian cells, passive anion ﬂow through a chloride channel
neutralizes this potential to allow acidiﬁcation to continue
(14–16). The importance of this counterion conductance in
regulating organelle pH is not clear, and probably varies for
different compartments [see (17) for review]. In some organ-
elles, such as phagosomes, the intrinsic counterion per-
meation is considerably higher than proton pumping activity
and is unlikely to contribute signiﬁcantly to pH regulation (18).
However, in other instances, it appears that counterion con-
ductance can modulate pH. For example, maximal acidiﬁ-
cation of endosomes isolated from proximal tubules is de-
pendent on chloride, and inhibitors of chloride channel activ-
ity reduce acidiﬁcation (19). Moreover, acidiﬁcation of
secretory granules in parafollicular cells induced by the se-
cretagogue thyrotropin was found to be mediated by an in-
crease in their chloride permeability (20).
The third component of pH regulation is the rate at which
protons exit a given compartment. All membranes are intrinsi-
cally permeable to protons at some level, and recent studies
have suggested that the proton leak rate is a key regulator of
pH in some organelles (8,12,21–23). Modeling studies by Wu
et al. suggested that the decrease in pH between successive
compartments along the secretory pathway was likely due to
a corresponding decrease in proton efﬂux coupled with an
increased V-ATPase pump density (21). The proton leak rate
in the TGN has also been measured using other techniques
and found to be quite high, but lower than that of earlier
Golgi compartments, consistent with the greater acidity of
the TGN (8). Interestingly, proton export from the TGN was
voltage-sensitive and inhibited by Zn2π, suggesting the in-
volvement of a regulated channel (8).
Organelle acidiﬁcation can be purposefully disrupted by vari-
ous agents, including weak bases, V-ATPase inhibitors, and
some ionophores. In addition, other conditions or treatments
may indirectly inﬂuencepH by less directmeans. For example,
expression of mutant dynamin in HeLa cells results in a sig-
niﬁcantlyelevatedendosomalpH,perhapsbyalteringendoso-
mallevelsofionchannelsortheV-ATPase(24).Thedissipation
of pH gradients in normally acidiﬁed compartments perturbs
protein sorting and transport along both the biosynthetic and
endocytic pathways, and also inhibits other functions such as
lysosomal degradation (9,10). There are also several diseases
inwhichproperacidiﬁcationofsomeorallorganelleshasbeen
suggested to be compromised. Recent examples have
emerged in which pathogenesis correlates with a change in
the function of various components that contribute to the
maintenance of steady-state organelle pH. Alterations in both
V-ATPase and counterion conductance function have been
postulated toaccount for the pleiotropicmanifestations in sev-
eral diseases. A few examples are discussed below.
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Altered pH in Cancer and Cell
Transformation
Many transformed cells appear to have abnormal organelle
and cytosolic pH, and there is some evidence that altered
pH may be important in the transformation process. In
1990, Jiang et al. demonstrated that ﬁbroblasts transform-
ed by transfection with the ras oncogene had signiﬁcantly
higher intralysosomal pH compared with nontransformed
parental cells (25). In addition, many tumor cell lines ex-
press V-ATPases at their plasma membranes, which may
contribute to their altered cytosolic pH (26). Evidence that
changes in cytosolic or organelle pH directly cause trans-
formation has been elusive, but an interesting but complex
picture is emerging from recent studies on cellular trans-
formation by bovine and human papillomaviruses (BPV and
HPV, respectively). These viruses, which cause squamous
cell cancers, encode three transforming proteins: E5, E6,
and E7. E5, which can transform cells even when ex-
pressed in the absence of E6 and E7, binds to growth
factor receptors EGF and PDGF and modulates their phos-
phorylation and internalization. However, receptor binding
can be dissociated from E5-mediated transformation, sug-
gesting that transformation occurs via an unrelated mech-
anism (27).
Several lines of evidence suggest that E5-mediated inhibition
of V-ATPase function causes cell transformation; however,
the mechanism and site of E5 action are controversial. Ex-
pression of HPV E5 in keratinocytes slowed endosomal acidi-
ﬁcation, and caused the intracellular accumulation of unde-
graded growth factor receptors (28). Another study in ﬁbro-
blasts also found that E5 expression blocked the delivery of
ﬂuorescent ﬂuid phase markers to late endosomal compart-
ments (29), consistent with the effects of pH perturbants on
endocytic trafﬁc observed by other laboratories (1,9). To-
gether, these studies suggested that E5-mediated disruption
of endosomal pH causes cell transformation by blocking
down-regulation of mitogenic signals.
In contrast, two groups have demonstrated that both HPV
and BPV E5 localize primarily to the Golgi complex rather
than to endosomes (30,31). Expression of BPV E5 resulted
in neutralization of Golgi pH by directly inhibiting V-ATPase
function, and mutants of E5 that did not disrupt Golgi pH
were unable to transform cells (30). Interestingly, mutations
in the 16kDa subunit that blocked V-ATPase function and dis-
rupted Golgi acidiﬁcation also caused cell transformation and
induced anchorage-dependent growth of ﬁbroblasts (30,32).
Moreover, transformation of ﬁbroblasts with E5 led to
changes in cell morphology and motility similar to those in-
duced by baﬁlomycin A1 treatment (33). However, transform-
ation of ﬁbroblasts by src or sis oncogene expression did not
affect Golgi pH, suggesting that alkalinization of the Golgi is
not obligatory for some pathways of cell transformation (30).
Thus, while it is likely that some transformation pathways re-
quire organelle pH perturbation, little is known about how this
pathway operates.Organelle Acidiﬁcation and Disease
Organelle Acidiﬁcation and Drug Resistance
The altered pH observed in transformed cells may also deter-
mine their sensitivity to drugs. Many chemotherapeutics, in-
cluding the anthracyclines (e.g. adriamycin and daunorubic-
in) and the vinca alkaloids (e.g. vinblastine and vincristine) are
weak bases with pKs of 7–8, and are normally sequestered in
acidiﬁed compartments. In untransformed cells, this limits
their access to targets in the nucleus and cytoplasm where
they cause cytotoxicity. Tumor cells, as noted above, typically
have elevated organelle pH, and are thus sensitive to the
cytotoxic effects of these drugs, which include the anthracyc-
line-mediated inhibition of topoisomerase and protein kinase
C activity and the disruption of microtubule organization by
vinca alkaloids [see (34,35) for reviews]. Drug-resistant tu-
mor cells typically have more alkaline cytoplasmic pH than
drug-sensitive lines (36), and it has been proposed that this
increased steady-state pH is responsible for the reduced ac-
cumulation of chemotherapeutics in the cytosol and nucleus
of drug-resistant compared with drug-sensitive cells (37).
Subsequent studies using MCF-7 breast cancer cells have
reﬁned this hypothesis to suggest that it is the pH gradient
between the cytoplasm and organelles (rather than cyto-
plasmic pH per se) that regulates cytosolic levels of chemo-
therapeutics. SNAFL-calcein measurements by Schindler
et al. demonstrated that intracellular organelles and vesicles
in these cells do not acidify normally, resulting in a decreased
pH gradient between the cytoplasm and the lumen (38,39)
(Figure 2A,B). Moreover, the TGN and recycling endosomes
are fragmented and dispersed throughout these cells (38).
Interestingly, an adriamycin-resistant subclone of these cells
demonstrated a normal acidiﬁcation proﬁle and organelle dis-
tribution pattern (Figure 2C). Disruption of vesicular acidiﬁ-
cation in these drug-resistant cells by the ionophores nigeric-
in or monensin, or by inhibition of V-ATPase activity using
baﬁlomycin A1 or concanamycin A, led to resensitization of
Figure2: Model for the restoration of drug sensitivity in tumor cells by tamoxifen. (A) Chemotherapeutic agents such as anthracyc-
lines and vinca alkaloids are weak bases and become sequestered in acidiﬁed compartments of normal cells (blue), thus diminishing their
concentration in the cytoplasm and nucleus (yellow). (B) Drug-sensitive tumor cells have higher cytoplasmic and organelle pH compared
with normal cells. In these cells, most chemotherapeutics are not efﬁciently sequestered and can access their cellular targets. (C) Drug-
resistant tumor cells have restored organelle acidiﬁcation, and like normal cells, can restrict the nuclear accumulation of weak base chemo-
therapeutics. (D) Tamoxifen disrupts the pH gradient across acidiﬁed compartments and thus blocks the sequestration of other chemothera-
peutics to restore drug sensitivity. The pH values are from references (38–40).
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the cells to adriamycin (38,39). Furthermore, adriamycin was
demonstrated to accumulate in acidic organelles in drug-re-
sistant but not drug-sensitive cells, thus correlating organelle
acidiﬁcation with effective drug sequestration (39). Together,
these studies suggest that drug sensitivity requires an acidi-
ﬁcation defect that blocks sequestration of chemothera-
peutics into acidic organelles, and that restoration of normal
acidiﬁcation induces drug resistance.
The link between organelle acidiﬁcation and drug seques-
tration was strengthened in recent experiments demonstrat-
ing that tamoxifen, which can resensitize drug-resistant tu-
mor cells to other chemotherapeutic agents, selectively al-
kalinizes acidiﬁed organelles without altering cytoplasmic pH
(40) (Figure 2D). As a result, chemotherapeutic drugs are
redistributed to the cytoplasm and nucleus in cells treated
with 0.5–10mM tamoxifen, well below the 30-mM concen-
tration attained when the drug is administered clinically (40).
The mechanism by which tamoxifen disrupts acidiﬁcation is
complex, and appears to involve an increase in proton leak
from acidiﬁed vesicles combined with a weak base effect
(41). This effect on organelle pH is independent of estrogen
receptor expression on the target cells and thus could ac-
count for some of the side-effects in nonreceptor-expressing
cells that have been observed with this drug (40).
Counterion Conductance-Mediated Changes
in Organelle Acidiﬁcation
In addition to cell transformation and cancer therapy, where
changes in organelle pH may be mediated by alterations in
V-ATPase activity or proton leak, there are also examples in
which changes in counterion conductance may cause defec-
tive organelle acidiﬁcation. Two genetic conditions, Dent’s
disease and cystic ﬁbrosis (CF), involve molecular defects inWeisz
chloride channels that may function to regulate organelle
acidiﬁcation in some cellular compartments. In the case of
Dent’s disease, a decrease in chloride permeability is thought
to directly affect endosomal function, whereas recent data
suggest that effects on sodium conductance are the primary
cause of pH dysregulation in cystic ﬁbrosis.
Dent’s disease
Dent’s disease is an X-linked renal disorder characterized by
low molecular-weight proteinuria, and also frequently associ-
ated with excess urinary secretion of phosphate and calcium
(hyperphosphaturia and hypercalciuria, respectively). While
there is signiﬁcant variability in the severity of this disease
among patients, common clinical symptoms include kidney
stones, rickets, and nephrocalcinosis (42). Several years ago,
the gene mutated in Dent’s disease was cloned and found
to encode CLC5, a member of the CLC family of chloride
channels (43,44). Mutations associated with Dent’s disease
tend to cluster in the transmembrane regions of CLC5, but
mutations in other regions have also been found (24,45).
As predicted, CLC5 expression is highest in kidney, but the
protein is also found in liver, brain, testes, and intestine.
Within the kidney, the protein is most highly expressed in
proximal tubule cells, and is also detected in intercalated cells
of the cortical collecting duct and in the thick ascending limb
of the loop of Henle (46–49). Within these cells, CLC5 local-
izes to subapical vesicles enriched in early endosomal
markers and to the apical membrane (46–49). This distri-
bution provides an intriguing clue to the clinical manifes-
tations of Dent’s disease: the proximal tubule of the kidney
is responsible for endocytosis of low molecular-weight pro-
teins that have passed through the glomerular ﬁlter. Interest-
ingly, both receptor-mediated and ﬂuid-phase endocytosis
were markedly reduced in proximal tubules of CLC5 knockout
mice compared with wild-type mice (50). Moreover, a direct
correlation between Cy5-conjugated b-lactoglobulin uptake
and CLC5 expression was observed in heterozygote females,
which express CLC5 in random tubules (50).
How does a defect in CLC5 cause disease? The prevailing
hypothesis is that CLC5 normally supplies the counterion
conductance required for renal endosome acidiﬁcation (49–
51). In support of this, preliminary data cited in (50) but not
yet published suggest that endosomes puriﬁed from CLC5-
knockout mice are slower to acidify than wild-type endosom-
es. While the defects in membrane trafﬁcking observed in
CLC5-knockout mice are certainly consistent with those ob-
served for cells in which organelle pH has been purposefully
disrupted, a deﬁnitive role for CLC5 in endosome acidiﬁcation
h a sy e tt ob ep r o v e n .
Defective acidiﬁcation in cystic ﬁbrosis
Cystic ﬁbrosis is the most common fatal autosomal recessive
disease affecting Caucasians, and occurs with an incidence
of about 1 in 2000 live births. Hallmarks of the disease in-
clude pulmonary accumulation of viscous mucus, chronic air-
way infection, pancreatic dysfunction, high levels of sweat
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chloride, and infertility in males. Cystic ﬁbrosis patients
usually die of respiratory failure resulting from pulmonary ob-
struction and inﬂammation. The biochemical defect in CF has
been traced to a defective chloride channel normally present
at the apical surface of epithelial cells [see (52) for review].
This cAMP-regulated channel (CFTR, for cystic ﬁbrosis trans-
membrane conductance regulator) is homologous to mem-
bers of the ATP-binding cassette protein family of trans-
porters. While mutations throughout the CFTR coding region
cause CF, one particular mutation, deletion of the phenylala-
nine residue at position 508, is particularly frequent and com-
prises nearly 70% of CF alleles (52).
Some studies have suggested that CFTR-mediated chloride
conductance regulates organelle pH in epithelial cells that
normally express this channel. The ‘acidiﬁcation hypothesis’
described by Barasch et al. (53,54) envisions a role for CFTR
in dissipating the membrane potential that would accumulate
during acidiﬁcation of the TGN and endosomal compart-
ments (similar to the postulated role of CLC5 in renal cells).
A slight elevation in the pH of the trans-Golgi/TGN of CF cells
might affect the glycosylation of newly synthesized glycocon-
jugates, which could explain the altered glycosylation of mu-
cins isolated from CF patients that has been observed by
many investigators [see (55) for review]. Intriguingly, a link
between altered pH and glycosylation has already been es-
tablished in tumor cells (56). In particular, glycoconjugates
isolated from CF samples were found to be hyperfucosylated,
hypersulfated, and hyposialylated compared with those ana-
lyzed in control samples. The accumulation of under-sialylat-
ed glycoconjugates at the cell surface of CF cells could also
account for the predisposition of CF patients to infection by
Pseudomonas aeruginosa bacteria, which have been dem-
onstrated to bind to asialoglycolipids (57,58).
In favor of this elegant hypothesis, Barasch et al. estimated,
using the membrane-permeant weak base DAMP, that TGN
and endosomal pH in several CF cell lines were elevated by
approximately 0.2 pH units compared to normal controls
(53,54). The same investigators also found that a light vesicle
fraction isolated from CF cells was slow to acidify compared
to normal (53). Acidiﬁcation of control cells required chloride
as a counterion, as no acidiﬁcation occurred in gluconate-
substituted buffer. Moreover, treatment with valinomycin
stimulated the acidiﬁcation rate of CF but not of control cells,
suggesting that acidiﬁcation of CF cells was limited by a low
chloride membrane conductance (53). Further support for
this hypothesis comes from measured increases in cell sur-
face levels of the asialoganglioside GA1 in immortalized CF
compared with normal cells, and a concomitant decrease in
the related monosialylated ganglioside GM1, raising the
possibility that GA1 accumulates because sialylation is inef-
ﬁcient in CF cells (53,59). Finally, Barasch et al. found that
degradation of endocytosed a2-macroglobulin was delayed
signiﬁcantly in CF compared to normal cells, although lysoso-
mal pH was unaltered, suggesting that defective endosomal
acidiﬁcation could account for the inefﬁcient sorting of this
protein to lysosomes (53).Organelle Acidiﬁcation and Disease
By contrast, other groups have found no evidence that CFTR
regulates organelle pH. No signiﬁcant change in the pH of
endosomes or the TGN was observed when CFTR was trans-
fected into CHO, 3T3, and L cells (60–63). This is not necess-
arily unexpected, as endogenous acidiﬁcation mechanisms
presumably operate normally in these cells regardless of
CFTR expression. In a more convincing study, however, Dunn
et al. used ﬂuorescence ratio imaging to carefully compare
endosomal pH in the CF pancreatic adenocarcinoma cell line
CFPAC-1 and a CFTR-rescued clone, and found no difference
between the two (64).
In addition, while there is considerable evidence that CF-de-
rived glycoconjugates differ from normal, it is not clear
whether this is due to altered Golgi pH in CF cells. One com-
plicating factor is that CF cells secrete large quantities of mu-
cin compared to normal cells (65), and it is difﬁcult to obtain
large enough quantities of normal mucin for detailed struc-
tural and compositional studies (66,67). Furthermore, not all
of the mucus-secreting cells in the airway express CFTR (68).
In addition, airway infection and inﬂammation can affect the
composition or structure of cell surface glycoconjugates and
mucous secretions isolated from CF patients (67,69,70).
Comparisons of glycosylation patterns in CF and control cell
lines have also yielded discrepant results. Decreased cell sur-
face levels of the asialoglycolipid GM1 were observed in air-
way epithelial cells in which CFTR activity was down-regu-
lated compared with their parental controls (71). Small differ-
ences in the sialic acid content of glycoconjugates were also
measured in these cells (72). By contrast, expression of CFTR
did not alter glycosylation of mucins in CFTR-expressing vs.
nonexpressing matched colon carcinoma cells (73). More-
over, our laboratory showed that differences in terminal gly-
cosylation between a CF cell line and its CFTR-rescued con-
trol were pH-independent and likely due to clonal drift (74).
Finally, while disruption of pH clearly slows biosynthetic traf-
ﬁc, newly synthesized proteins were delivered to the cell sur-
face with identical rates in CF cells and functionally rescued
controls (75).
In a surprising twist, two recent reports have found that TGN
pH in CF cells is hyperacidiﬁed compared with control cells.
Chandy et al. performed ﬂuorescence ratio imaging of pH-
sensitive GFP-sialyltransferase chimeras to measure trans-
Golgi pH in several cell lines (76). Interestingly, Golgi pH was
0.2 pH units lower in CF cells compared with genetically
matched rescued cells (6.7 vs. 6.9, respectively). This differ-
ence was statistically signiﬁcant, but considered unlikely to
be physiologically important (76,77). Interestingly, Golgi pH
measured in HeLa cells using the same method was
considerably lower (pH6.4), suggesting a differences in
V-ATPase pumping activity between the two cell types (76).
Using a similar approach, in which TGN pH was quantitated
using a pH-sensitive GFP-TGN38 chimera, Poschet et al.
found a more sizable acidiﬁcation in CF cells relative to con-
trol (78). The TGN pH of CF cells in these experiments was
6.2 [compared with 6.7 measured in the same cells by Chan-
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dy et al. (76)], whereas rescued cells had an increased pH of
6.7 (78). In addition, this group also found that endosomal
pH was also hyperacidiﬁed in CF cells, and that TfR recycling
was altered (79). The TGN and endosomal hyperacidiﬁcation
observed in CF cells was Naπ dependent, suggesting that
CFTR regulation of Naπ/Kπ-ATPase or epithelial sodium
channel activity was responsible (78,79). Indeed, CFTR has
been found to modulate the activity of numerous other ion
transporters and channels (80). Thus, according to this
model, the lack of CFTR in an acidiﬁed compartment might
decrease Naπ/Kπ-ATPase-mediated Naπ inﬂux or increase
channel-mediated Naπ efﬂux and thereby lower the mem-
brane potential to enable hyperacidiﬁcation.
The dramatic difference in TGN pH measured in the same
cell lines by the two groups is likely not due to differential
localization of the pH probes used, as the distribution of the
GFP-TGN38 chimera overlapped nearly completely with co-
expressed myc-tagged sialyltransferase (78). Moreover, lectin
binding experiments suggested that CF cell glycoconjugates
were hyposialylated compared with rescued controls, as pre-
dicted by the acidiﬁcation hypothesis (78). Thus, while it is
difﬁcult to explain why airway cells (both wild-type and
CFTR-corrected) appear to have markedly elevated TGN pH
compared to other cell lines, it is possible that hyper-
acidiﬁcation of the TGN could account for the altered
glycosylation proﬁle of CF cells previously observed by
others. The exact mechanism by which CFTR regulates or-
ganelle pH, however, remains to be elucidated.
Concluding Remarks
It is clear that acidiﬁcation of a subset of intracellular com-
partments is required for normal homeostasis. Multiple
mechanisms contribute to the maintenance of organelle pH,
and there is accumulating evidence that altered pH regulation
is a hallmark of some disease states. For example, global
effects on organelle acidiﬁcation due to altered V-ATPase ac-
tivity, levels, or localization have been shown to correlate with
cell transformation. Furthermore, the restoration of regulated
organelle pH in some tumor cells may contribute to their ac-
quired resistance to chemotherapeutic drugs. Indeed, the ef-
ﬁcacy of some chemotherapeutic agents such as tamoxifen
that are particularly useful in treating drug-resistant tumors
may be related to their ability to reverse such changes in
organelle pH. In addition, changes in organelle pH may ex-
plain many of the symptoms observed in Dent’s disease and
cystic ﬁbrosis.
Despite these tantalizing links, there is as yet no deﬁnitive
example where a defect in acidiﬁcation is the primary cause
of disease pathogenesis. In part, this is because our under-
standing of how acidiﬁcation contributes to cell homeostasis
remains somewhat limited. For example, experimental data
using different pH perturbants have yielded somewhat dis-
crepant results regarding the role of acid pH in various mem-
brane sorting and trafﬁcking steps (10). In part, these discre-Weisz
pancies are due to our limited ability to selectively disrupt
the pH of individual compartments (81); moreover, many pH
perturbants are known to indirectly compromise other cellular
functions (10). Finally, the components that regulate organelle
pH have additional roles. For example, in addition to their
functions as part of the V-ATPase holoenzyme, individual sub-
units and combinations of V-ATPase subunits have been sug-
gested to participate in the regulation of homotypic mem-
brane fusion, endocytosis, and other membrane trafﬁcking
events (82,83). Similarly, a regulatory role for CFTR in mem-
brane trafﬁc has been proposed that may involve pH-inde-
pendent interactions with trafﬁcking machinery (84). A better
understanding of how these various components normally
function together to regulate pH in different cell types and
compartments will provide a stronger foundation with which
to interpret the studies described above.
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